BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 36948592)

  • 1. Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research.
    Cronin JM; Yu AM
    Drug Metab Dispos; 2023 Jun; 51(6):685-699. PubMed ID: 36948592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Advances in Novel Recombinant RNAs for Studying Post-transcriptional Gene Regulation in Drug Metabolism and Disposition.
    Tu MJ; Yu AM
    Curr Drug Metab; 2023; 24(3):175-189. PubMed ID: 37170982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel RNA molecular bioengineering technology efficiently produces functional miRNA agents.
    Traber GM; Yi C; Batra N; Tu MJ; Yu AM
    RNA; 2024 May; 30(6):680-694. PubMed ID: 38429100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioengineered miR-27b-3p and miR-328-3p modulate drug metabolism and disposition
    Li X; Tian Y; Tu MJ; Ho PY; Batra N; Yu AM
    Acta Pharm Sin B; 2019 May; 9(3):639-647. PubMed ID: 31193825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and Purification of tRNA/ pre-miRNA-Based Recombinant Noncoding RNAs.
    Tu MJ; Wright HK; Batra N; Yu AM
    Methods Mol Biol; 2021; 2323():249-265. PubMed ID: 34086286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding microRNAs: small RNAs play a big role in regulation of ADME?
    Yu AM; Pan YZ
    Acta Pharm Sin B; 2012 Apr; 2(2):93-101. PubMed ID: 32154096
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Li PC; Tu MJ; Ho PY; Batra N; Tran MML; Qiu JX; Wun T; Lara PN; Hu X; Yu AX; Yu AM
    Theranostics; 2021; 11(10):4858-4871. PubMed ID: 33754032
    [No Abstract]   [Full Text] [Related]  

  • 8. RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies.
    Traber GM; Yu AM
    J Pharmacol Exp Ther; 2023 Jan; 384(1):133-154. PubMed ID: 35680378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of
    McDougall R; Ramsden D; Agarwal S; Agarwal S; Aluri K; Arciprete M; Brown C; Castellanos-Rizaldos E; Charisse K; Chong S; Cichocki J; Fitzgerald K; Goel V; Gu Y; Guenther D; Habtemariam B; Jadhav V; Janas M; Jayaraman M; Kurz J; Li J; Liu J; Liu X; Liou S; Maclauchlin C; Maier M; Manoharan M; Nair JK; Robbie G; Schmidt K; Smith P; Theile C; Vaishnaw A; Waldron S; Xu Y; Zhang X; Zlatev I; Wu JT
    Drug Metab Dispos; 2022 Jun; 50(6):781-797. PubMed ID: 34154993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioengineering of a single long noncoding RNA molecule that carries multiple small RNAs.
    Petrek H; Batra N; Ho PY; Tu MJ; Yu AM
    Appl Microbiol Biotechnol; 2019 Aug; 103(15):6107-6117. PubMed ID: 31187211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioengineered non-coding RNA agent (BERA) in action.
    Duan Z; Yu AM
    Bioengineered; 2016 Nov; 7(6):411-417. PubMed ID: 27415469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective Therapy.
    Yu AM; Tian Y; Tu MJ; Ho PY; Jilek JL
    Drug Metab Dispos; 2016 Mar; 44(3):308-19. PubMed ID: 26566807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioengineering of noncoding RNAs for research agents and therapeutics.
    Ho PY; Yu AM
    Wiley Interdiscip Rev RNA; 2016; 7(2):186-97. PubMed ID: 26763749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current trends in drug metabolism and pharmacokinetics.
    Li Y; Meng Q; Yang M; Liu D; Hou X; Tang L; Wang X; Lyu Y; Chen X; Liu K; Yu AM; Zuo Z; Bi H
    Acta Pharm Sin B; 2019 Nov; 9(6):1113-1144. PubMed ID: 31867160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel approaches for efficient  in vivo fermentation production of noncoding RNAs.
    Yu AM; Batra N; Tu MJ; Sweeney C
    Appl Microbiol Biotechnol; 2020 Mar; 104(5):1927-1937. PubMed ID: 31953559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development.
    Tibbitts J; Canter D; Graff R; Smith A; Khawli LA
    MAbs; 2016; 8(2):229-45. PubMed ID: 26636901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Progress on Mass Spectrum Based Approaches for Absorption, Distribution, Metabolism, and Excretion Characterization of Traditional Chinese Medicine.
    Bai X; Zhu C; Chen J; Jiang X; Jin Y; Shen R; Zhu M; Wu C
    Curr Drug Metab; 2022; 23(2):99-112. PubMed ID: 35152864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of Drug-Metabolizing Enzymes and Transporters in Human Tissue Biopsy Samples: A Review of the Literature.
    Rodrigues AD; Rowland A
    J Pharmacol Exp Ther; 2020 Mar; 372(3):308-319. PubMed ID: 31879375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioengineered RNA Therapy in Patient-Derived Organoids and Xenograft Mouse Models.
    Tu MJ; Yi CM; Traber GM; Yu AM
    Methods Mol Biol; 2022; 2521():191-206. PubMed ID: 35732999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development.
    Lombardo F; Desai PV; Arimoto R; Desino KE; Fischer H; Keefer CE; Petersson C; Winiwarter S; Broccatelli F
    J Med Chem; 2017 Nov; 60(22):9097-9113. PubMed ID: 28609624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.